| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.3M | -46.9% | -43.9% |
| Cost of Revenue | $1.5M | -54.1% | -53.8% |
| Gross Profit | $1.9M | -39.4% | -32.4% |
| R&D Expense | $1.1M | -25.3% | +39.8% |
| SG&A Expense | $3.5M | -4.8% | -22.2% |
| Operating Income | -$5.2M | +47.3% | +49.1% |
| Pre-tax Income | -$375K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.7M | -44.5% | -81.7% |
| Accounts Receivable | $3.6M | +12.8% | +21.2% |
| Inventory | $2.0M | -61.6% | -44.6% |
| Current Assets | $18.4M | -17.5% | -50.8% |
| Total Assets | $29.4M | -13.1% | -39.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.0M | — | — |
| Capital Expenditures | $1.0M | — | — |
| Investing Cash Flow | -$1.0M | — | — |
| Financing Cash Flow | $12.5M | — | — |
| Free Cash Flow | -$21.0M | — | — |
| +96.1% |
| -129.0% |
| Income Tax | $8K | +0.0% | +0.0% |
| Net Income | -$3.9M | +59.8% | -400.8% |
| EPS (Basic) | -$0.09 | +60.9% | -400.0% |
| EPS (Diluted) | -$0.19 | +26.9% | +42.4% |
| $41.3M |
| +8.9% |
| +4.2% |
| Long-term Debt | $26.1M | +3.9% | +15.3% |
| Total Liabilities | $73.3M | -3.1% | -17.3% |
| Stockholders' Equity | -$43.9M | -5.0% | -9.1% |